Use of the Levonorgestrel Intrauterine Device in an Adolescent with Type IV Vascular Ehlers-Danlos Syndrome and Heavy Menstrual Bleeding, a Case Report.
J Pediatr Adolesc Gynecol
; 36(3): 331-333, 2023 Jun.
Article
en En
| MEDLINE
| ID: mdl-36813023
BACKGROUND: Ehlers-Danlos syndrome (EDS) is a group of connective tissue disorders of altered collagen synthesis. People with vascular EDS are at increased risk for vascular and hollow viscous rupture. Heavy menstrual bleeding (HMB) is common among adolescents with EDS. The levonorgestrel intrauterine device (LNG-IUD) is an effective treatment option for HMB; however, its use in patients with vascular EDS has historically been avoided due to perceived risk of uterine rupture. This is the first known case report on use of the LNG-IUD in an adolescent with vascular EDS. CASE: A 16-year-old female with vascular EDS and HMB underwent placement of the LNG-IUD. Placement of the device was performed in the operating room under ultrasound guidance. At the 6-month follow-up, the patient reported significant improvement in bleeding and high satisfaction. No complications were identified at the time of placement or follow-up. SUMMARY AND CONCLUSION: LNG-IUD may be a safe and effective option for menstrual management in individuals with vascular EDS.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Anticonceptivos Femeninos
/
Síndrome de Ehlers-Danlos
/
Síndrome de Ehlers-Danlos Tipo IV
/
Dispositivos Intrauterinos Medicados
/
Menorragia
Tipo de estudio:
Etiology_studies
/
Guideline
/
Prognostic_studies
Límite:
Adolescent
/
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
J Pediatr Adolesc Gynecol
Asunto de la revista:
GINECOLOGIA
/
PEDIATRIA
Año:
2023
Tipo del documento:
Article